These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23947360)

  • 21. [Research and development strategies, examples among new vaccines].
    Denis F; Ploy MC
    Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections.
    Calzas C; Chevalier C
    Front Immunol; 2019; 10():1605. PubMed ID: 31379823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Route of infectious bronchitis virus vaccination determines the type and magnitude of immune responses in table egg laying hens.
    Al-Rasheed M; Ball C; Ganapathy K
    Vet Res; 2021 Nov; 52(1):139. PubMed ID: 34772449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systems Biological Analysis of Immune Response to Influenza Vaccination.
    Cortese M; Sherman AC; Rouphael NG; Pulendran B
    Cold Spring Harb Perspect Med; 2021 Jun; 11(6):. PubMed ID: 32152245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Basis of Coronavirus Virulence and Vaccine Development.
    Enjuanes L; Zuñiga S; Castaño-Rodriguez C; Gutierrez-Alvarez J; Canton J; Sola I
    Adv Virus Res; 2016; 96():245-286. PubMed ID: 27712626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stressor-induced alterations of adaptive immunity to vaccination and viral pathogens.
    Powell ND; Allen RG; Hufnagle AR; Sheridan JF; Bailey MT
    Immunol Allergy Clin North Am; 2011 Feb; 31(1):69-79. PubMed ID: 21094924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Harnessing innate and adaptive immunity for viral vaccine design.
    Jost S; Altfeld M; Chang JJ
    Expert Rev Vaccines; 2012 Jul; 11(7):775-7. PubMed ID: 22913253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hatchery Vaccination Against Poultry Viral Diseases: Potential Mechanisms and Limitations.
    Abdul-Cader MS; Palomino-Tapia V; Amarasinghe A; Ahmed-Hassan H; De Silva Senapathi U; Abdul-Careem MF
    Viral Immunol; 2018; 31(1):23-33. PubMed ID: 28714781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How innate immune mechanisms contribute to antibody-enhanced viral infections.
    Ubol S; Halstead SB
    Clin Vaccine Immunol; 2010 Dec; 17(12):1829-35. PubMed ID: 20876821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular sensing of viral DNA by the innate immune system.
    Mansur DS; Smith GL; Ferguson BJ
    Microbes Infect; 2014 Dec; 16(12):1002-12. PubMed ID: 25316508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles-derived vaccines to prevent emerging viral diseases.
    Frantz PN; Teeravechyan S; Tangy F
    Microbes Infect; 2018; 20(9-10):493-500. PubMed ID: 29410084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploiting Mucosal Immunity for Antiviral Vaccines.
    Iwasaki A
    Annu Rev Immunol; 2016 May; 34():575-608. PubMed ID: 27168245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines.
    Cheng X; Eisenbraun M; Xu Q; Zhou H; Kulkarni D; Subbarao K; Kemble G; Jin H
    PLoS One; 2009; 4(2):e4436. PubMed ID: 19209231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial overview: Preventive and therapeutic vaccines: Vaccination against viral disease - current advances and challenges.
    Rappuoli R; Sutter G
    Curr Opin Virol; 2017 Apr; 23():vi-viii. PubMed ID: 28622999
    [No Abstract]   [Full Text] [Related]  

  • 40. Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines.
    Jennings GT; Bachmann MF
    Curr Mol Med; 2007 Mar; 7(2):143-55. PubMed ID: 17346167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.